Ki sa "Klè" vle di?
Bèt la pa pote mitasyon an. Li pa pral devlope maladi a epi yo pa pral pase li sou.
Chat Alfa Mannosidoz (AlphaMan)
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder affecting cats, caused by a deficiency of the enzyme alpha-mannosidase. This DNA test helps identify carriers and affected cats, enabling responsible breeding decisions to prevent the spread of the disease. Early detection through the Alpha Mannosidosis DNA test is crucial for managing symptoms and improving feline health. By screening your cat, you contribute to reducing the incidence of AlphaMan in future generations. Trusted by veterinarians and breeders, this test provides accurate and reliable results. Ensure your cat’s well-being with the Alpha Mannosidosis DNA test today. Protect your feline companion from hereditary health risks with this essential genetic screening.
Abreviyasyon: AlphaMan
Analize mitasyon: MAN2B1 c.1749_1752del
Eritaj: Otozomal resesif
Akwonim
AlphaMan
Obsève frekans
Gravite nan klinik
Klasifikasyon klinik
Maladi Metabolik
Analize mitasyon
MAN2B1 c.1749_1752del
p.(Q584Afs)
p.(Q584Afs)
Mòd eritaj
Otozomal resesif
Rezime tès la:
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder in cats caused by a deficiency of the enzyme alpha-mannosidase. This leads to the accumulation of complex sugars in cells, resulting in progressive neurological and physical symptoms. A DNA test for AlphaMan helps identify carriers and affected cats, enabling responsible breeding decisions. Early detection through testing can improve management and care for affected cats. Genetic screening is essential to reduce the incidence of this debilitating condition in feline populations.
Disponib nan pake a: Basic
Tès ADN sa a enkli apati pake nou an Basic — epi tou se yon pati nan pake yo Basic, Standard, Advanced, Complete.
Gade pake tès ADN →Chwazi pake ki pi byen adapte elvaj ou oswa estrateji sante bèt ou yo.
Understanding Alpha Mannosidosis in Cats
Alpha Mannosidosis (AlphaMan) is a rare genetic disorder that affects the metabolism of certain sugars in the body. It is caused by a deficiency in the enzyme alpha-mannosidase, which is responsible for breaking down mannose-containing oligosaccharides. When this enzyme is deficient or absent, these sugars accumulate in the body's cells, leading to a range of health issues.
Symptoms and Clinical Manifestations
Cats with Alpha Mannosidosis may exhibit a variety of clinical symptoms that can vary in severity. Common signs include neurological deficits, such as poor coordination, muscle weakness, and behavioral changes. Additionally, affected cats might experience growth delays, skeletal abnormalities, and impaired immune function. The onset of symptoms can occur at different ages, often leading to a progressive decline in health over time.
Diagnosis of Alpha Mannosidosis
Diagnosing Alpha Mannosidosis typically involves a combination of clinical evaluation and laboratory testing. A veterinarian will assess the cat's medical history and symptoms, followed by conducting biochemical tests to measure enzyme activity. Genetic testing through DNA analysis can confirm the presence of mutations in the gene responsible for encoding the alpha-mannosidase enzyme, providing a definitive diagnosis.
Opsyon Jesyon ak Tretman
Currently, there is no cure for Alpha Mannosidosis, and treatment is primarily supportive. Management strategies may include symptomatic care to improve the quality of life for affected cats. This can involve nutritional support, physical therapy, and regular veterinary check-ups to monitor the animal's condition. Research is ongoing to explore potential therapeutic options, including enzyme replacement therapy and gene therapy, which may offer hope for future treatments.
The Importance of Genetic Testing
Genetic testing for Alpha Mannosidosis is crucial for breeders and pet owners to identify carriers of the gene mutation and prevent the propagation of this disorder. By understanding the genetic status of their cats, responsible breeding practices can be implemented to reduce the risk of this condition in future generations. Additionally, early detection through DNA testing can help owners make informed decisions regarding the health management of their pets.
Race rekonèt pou tès la: Alfa Mannosidoz (AlphaMan)
- Persian
🧬 Interpretation of genotypes AlphaMan
Jenotip
Estati
🟡 N/N
Ki pa konpayi asirans - Pa gen risk
🟡 N/AlphaMan
Konpayi asirans - Pa gen risk
❌ AlphaMan/AlphaMan
Afekte - Nan Risk
FAQ: konprann entèpretasyon an
Èske yon "Carrier" serye?
Non. Bèt la jeneralman an sante men li ka transmèt mitasyon an bay li pitit pitit.
E si yon bèt "Afekte"?
Li pote de kopi mitasyon. Siy klinik yo espere depann sou maladi a. Li pa ta dwe elve.
Poukisa gen diferans ant gason / fi?
Gen kèk maladi ki lye ak sèks, kidonk ekspresyon yo varye selon la sèks bèt.
Predi pitit pitit
N/N (ki-pa-transpote)
N/AlphaMan (Carrier)
AlphaMan/AlphaMan (Afekte)
FAQ Tès ADN
Kisa tès ADN sa a detekte?
This DNA test detects the mutation associated with Alpha Mannosidosis (AlphaMan) in order to identify clear, carrier, or at-risk animals.
Poukisa teste yon bèt elvaj?
Tès ADN ede elve yo planifye kwazman ki pi an sekirite epi redwi risk pou yo transmèt mitasyon an bay pitit pitit yo.
Ki mòd eritaj tès sa a?
Mòd eritaj ki rapòte pou tès sa a se otozomal resesif.
Ki mitasyon ki analize nan tès sa a?
This test analyses the mutation MAN2B1 c.1749_1752del.
Èske yon bèt transporteur nesesèman afekte?
Pa nesesèman. Entèpretasyon depann sou modèl eritaj la ak jenotip ki kapab lakòz.
Referans
Berg T, Tollersrud O K, Walkley S U, Siegel D, Nilssen O. Purification of feline lysosomal alpha-mannosidase, determination of its cDNA sequence and identification of a mutation causing alpha-mannosidosis in Persian cats. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):863-70. doi: 10.1042/bj3280863.